Neuromelanin and melanin (NM) (NM)

Neuromelanin is a dark, insoluble pigment found primarily in the catecholaminergic neurons of the substantia nigra and locus coeruleus (Zecca et al., 2003, Nature Reviews Neuroscience). It is a complex biopolymer synthesized from the oxidation of dopamine and norepinephrine, functioning as a double-edged sword: it provides neuroprotection by sequestering toxic metals like iron and organic cations, but its release into the extracellular space during neuronal death triggers chronic neuroinflammation (Sulzer et al., 2018, PNAS). Melanin, the broader class of pigments found in the skin, hair, and eyes, primarily serves to protect tissues from ultraviolet radiation and oxidative stress (StatPearls, 2023). While not a classical therapeutic target such as a receptor or enzyme, melanin is highly significant in pharmacology due to its ability to bind and accumulate various drugs, including chloroquine and phenothiazines, which can lead to adverse effects like retinopathy (Bridelli et al., 2006, Pigment Cell Research). In neurodegenerative research, neuromelanin serves as a vital imaging biomarker; neuromelanin-sensitive MRI is used to track the progression of Parkinson's disease by measuring the loss of pigmented neurons (Sasaki et al., 2006, NeuroReport). The pigment's high affinity for metal ions allows it to act as a buffer for redox-active metals, though this capacity can be overwhelmed in disease states, contributing to oxidative damage.

Other names

EumelaninPheomelaninNeuromelaninNMBrain pigment

Neuromelanin and melanin do not function as classical drug targets; instead, they act as biological sequestration sites that bind various drugs and metal ions through ionic, hydrophobic, and charge-transfer interactions (Bridelli et al., 2006, Pigment Cell Research). This binding can lead to the accumulation of drugs in pigmented tissues, potentially causing localized toxicity or altering the pharmacokinetics of the compounds (PubMed, PMID: 16524427).